Evidence suggests that combining metformin with standard of care could increase survival and offer other benefits to patients with high-volume disease.

Researchers sought to determine whether DNA methylation markers could be helpful in risk stratification for patients with AML and normal cytogenetics.

Researchers sought to determine the effects of multidisciplinary team-style continuity of care with nutritional nursing in patients with lung cancer receiving postoperative chemotherapy.

Ravi B Parikh, MD, MPP discusses the current and future use of artificial intelligence (AI) in the greater US health care ...

An intervention reduced the percentage of prior authorizations that were delayed or denied from 32% to 8%. A multi-pronged intervention reduced prior authorization delays and denials for patients ...

Data suggest that cabozantinib and pembrolizumab can be effective in patients with advanced gastric or gastroesophageal junction cancer whose disease is resistant or refractory to immune checkpoint ...

Investigators report findings from a phase 3 trial demonstrating that transdermal estradiol patches were as effective as luteinizing hormone-releasing hormone agonists.

Cell-free DNA blood tests (cf-bDNA) may be more costly and less effective for colorectal cancer (CRC) screening than other screening modalities, according to a study published online Oct. 29 in the ...

The median progression-free survival was 12.5 months in the treatment-naïve cohort and 5.5 months in the previously treated cohort. The researchers evaluated capmatinib in the phase 2 GEOMETRY mono-1 ...

Researchers sought to determine whether combination decitabine, venetoclax, and ponatinib would be effective in patients with accelerated phase CML.

Atezolizumab did not improve overall survival, progression-free survival, distant metastasis-free survival, or time to local failure.

Researchers sought to determine whether a low dose of bosutinib followed by escalation would be effective for patients with CML.